Quadrature Capital’s Vigil Neuroscience VIGL Stock Holding History

Quadrature Capital’s Portfolio VIGL Stock Details VIGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-62,271	Closed	-$495K	–	1521
2025 Q2	$495K	Buy	+62,271	New	+$279K	0.01%	576

Other funds holding VIGL

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Quadrature Capital's VIGL Position: Q3 2025 in Review

Quadrature Capital sold out of Vigil Neuroscience (VIGL) in Q3 2025, closing a stake of 62,271 shares — an estimated $495K sold.

Quadrature Capital first reported a position in VIGL in Q2 2025 and held it in 1 quarter. The position peaked at $495K in Q2 2025. 2 funds tracked by Wall St. Rank hold VIGL as of Q3 2025.

Quadrature Capital reported no remaining Vigil Neuroscience position as of Q3 2025 after selling out during the quarter.
Quadrature Capital sold 62,271 Vigil Neuroscience shares in Q3 2025, an estimated $495K.
Quadrature Capital first reported a position in Vigil Neuroscience in Q2 2025 and held it in 1 quarter.
Quadrature Capital's Vigil Neuroscience position peaked at $495K in Q2 2025.
2 funds tracked by Wall St. Rank held Vigil Neuroscience as of Q3 2025.

Based on Quadrature Capital's 13F filing for Q3 2025, filed 13 Nov 2025.